Search Articles — Sudonull

https://sudonull.com/group-intelligence-ants-and-human-evolution

Explore the evolution of collective intelligence from ant swarms to Homo sapiens migrations. Key stages of brain growth, tools, and cultural exchange. Dive into facts for AI developers.

https://sudonull.com/bird-intelligence-tests-and-neurons

Learn how bird IQ is measured: mirror test, Aesop's fable, neuronal density. Corvids and parrots exceed expectations. Read about leaders in cognitive abilities.

https://sudonull.com/types-of-artificial-intelligence-classification-and-application

Learn about four key approaches to creating AI outside of neural networks. Comparison of advantages and limitations for developers. Read more!

https://sudonull.com/apple-intelligence-and-siri-ai-at-wwdc-2026-a-new-era-or-a-failure

Analyzing WWDC 2026: Why Apple Outsourced AI Backend to Google, Tim Cook's Departure, Privacy Risks, and New Siri Rules. Read the Details.

https://sudonull.com/how-does-artificial-intelligence-work-in-simple-terms-explained

Learn how does artificial intelligence work in simple terms. Discover how neural networks learn patterns and why AI is pattern-matching, not thinking. Read now.

https://ymaho.com/intellia-crispr-therapy-fda-filing-for-lonvo-z-for-hae

Intellia has filed the world's first application for an in vivo CRISPR therapy, lonvo-z, for hereditary angioedema (HAE). 87% reduction in attacks, 62% attack-free. Risk, market, and forecast analysis. Read.

https://ymaho.com/intellia-crispr-therapy-phase-3-data-on-edema-breakthrough

Intellia presented long-awaited phase III data of CRISPR therapy lonvo-z for hereditary angioedema: 87% reduction in attacks, 62% of patients attack-free. Learn about the breakthrough in in vivo genome editing.

https://ymaho.com/crispr-therapy-hae-phase-3-data-from-intellia-at-eaaci-2026

Intellia presented the long-awaited results of phase 3 of CRISPR therapy lonvoguran ziclumeran for hereditary angioedema. Reduction of attacks by 87%, 62% of patients without therapy. Learn more.

https://ymaho.com/crispr-therapy-in-vivo-intellia-study-87-efficacy-in-hae

Phase 3 HAELO: single CRISPR infusion reduced hereditary angioedema attacks by 87% vs placebo. First in vivo therapy on the verge of registration. Details, insights, forecasts.

https://ymaho.com/in-vivo-gene-editing-crispr-therapy-for-hereditary-angioedema

Single-dose CRISPR therapy NTLA-2002 reduced hereditary angioedema attacks by 87% in phase III. Learn how this will change treatment and pave the way to a cure.

https://ymaho.com/in-vivo-gene-editing-phase-3-of-hae-therapy-successful

First ever successful phase 3 in vivo gene editing: lonvo-z therapy reduces HAE attacks by 87%. Learn about the breakthrough and discontinuation of prophylaxis.

https://ymaho.com/emotional-intelligence-in-hair-care-shower-therapy-2026

53% of buyers choose shampoos for healing, not effect. How brands sell relaxation and replace the clinic with the forest. Read the trend analysis.

https://ymaho.com/emotional-intelligence-what-it-is-and-how-to-develop-it-complete-guide

What is emotional intelligence and how to develop it? 4 components, 5 steps, and self-regulation techniques. Develop EQ and improve relationships. Read now!

https://ymaho.com/grinex-hack-6-5-million-stolen-but-not-by-intelligence-agencies

Experts explained why the attack on Grinex was carried out by ordinary hackers rather than state actors. Learn how this affects the security of your assets.

https://ymaho.com/how-ai-is-changing-crypto-liquidity-and-markets

Discover how artificial intelligence is smoothing crypto markets, reducing slippage, and improving liquidity for everyday traders. Learn the basics now.